Status:
RECRUITING
Genetics of Insulin and Incretins in Cystic Fibrosis
Lead Sponsor:
Children's Hospital of Philadelphia
Collaborating Sponsors:
University of Pennsylvania
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
2+ years
Brief Summary
Cystic fibrosis related diabetes (CFRD) is associated with worse CF-relevant outcomes. The mechanisms underlying CFRD development are not fully understood, but recent evidence suggests Type 2 Diabete...
Detailed Description
CFRD is associated with worse nutritional status, greater pulmonary function decline, and increased mortality, highlighting its relevance in CF and arises primarily from compromised insulin secretion-...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Subjects age \>2y
- Diagnosis of Cystic Fibrosis
- For subjects\< 18 years, parental/guardian permission (informed consent) and if appropriate, child assent
- Exclusion Criteria 1. Established diagnosis of non-CFRD (cystic fibrosis related diabetes) (e.g T1DM)
- .
Exclusion
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
550 Patients enrolled
Trial Details
Trial ID
NCT01852448
Start Date
May 1 2013
End Date
July 1 2026
Last Update
July 25 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The Children's Hopsital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104
2
The University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104